Skip to main content
. Author manuscript; available in PMC: 2018 Sep 10.
Published in final edited form as: J Pharm Biomed Anal. 2016 Nov 11;144:154–158. doi: 10.1016/j.jpba.2016.11.003

Table 1.

Parameters for SRM transitions for FPLTSFR and TITTDLLGSPFQEK. Q1, Q3, DP, CE, CXP for the different transitions for both the standards and internal standards are enlisted.

Q1 Q3 DP(V) CE(V) CXP(V)
FPLTSFR 434.24 360.69 116 23 14
434.24 623.351 45 25 10
434.24 510.26 45 25 10
434.24 720.40 45 25 10
FPLTSFR (HEAVY PEPTIDE) 439.3 520.3 91 29 16
439.3 365.4 117 23 16
TITTDLLGSPFQEK 775.408 792.389 86 33 36
775.408 648.335 86 33 36
775.408 905.473 120 36 10
775.408 1018.57 43 38 10
TITTDLLGSPFQEK
(HEAVY PEPTIDE)
779.510 800.430 86 33 36
779.510 656.381 86 47 18